Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared on X:
“Myeloma Paper of the Day:
Study of Black pts w/ NDMM in triplet and quadruplet era finds OS 5 years comparable to White pts in unadjusted and overlap weighted analyses; lower risk of all-cause mortality 5 years after adjustment for relevant variables.”
Title: Overall survival of Black patients with newly diagnosed multiple myeloma in the era of triplet and quadruplet therapies
Authors: Hamlet Gasoyan, Shahzad Raza, Michael B. Rothberg, Jeffrey D. Kovach, Nicholas J. Casacchia, Jason Valent, Faiz Anwer
You can read the full article on Blood Cancer Journal.
You can find other articles featuring Robert Orlowski on OncoDaily.
